Published in Mol Cell Biol on April 01, 1999
Control of the replicative life span of human fibroblasts by p16 and the polycomb protein Bmi-1. Mol Cell Biol (2003) 4.05
The nature of telomere fusion and a definition of the critical telomere length in human cells. Genes Dev (2007) 1.88
Downregulation of 14-3-3sigma prevents clonal evolution and leads to immortalization of primary human keratinocytes. J Cell Biol (2000) 1.81
Analysis of ku80-mutant mice and cells with deficient levels of p53. Mol Cell Biol (2000) 1.54
ING2 regulates the onset of replicative senescence by induction of p300-dependent p53 acetylation. Mol Cell Biol (2005) 1.31
Uncoupling between phenotypic senescence and cell cycle arrest in aging p21-deficient fibroblasts. Mol Cell Biol (2000) 1.24
CDK4 and CDK6 delay senescence by kinase-dependent and p16INK4a-independent mechanisms. Mol Cell Biol (2007) 1.16
Loss of retinoblastoma but not p16 function allows bypass of replicative senescence in human fibroblasts. EMBO Rep (2003) 1.10
Senescent mouse cells fail to overtly regulate the HIRA histone chaperone and do not form robust Senescence Associated Heterochromatin Foci. Cell Div (2010) 1.05
Evidence for a telomere-independent "clock" limiting RAS oncogene-driven proliferation of human thyroid epithelial cells. Mol Cell Biol (2000) 1.02
p16INK4a-induced senescence is disabled by melanoma-associated mutations. Aging Cell (2008) 1.01
Senescence at a glance. J Cell Sci (2013) 0.88
Malignancy without immortality? Cellular immortalization as a possible late event in melanoma progression. Pigment Cell Melanoma Res (2011) 0.87
Wnt-signaling and senescence: A tug of war in early neoplasia? Cancer Biol Ther (2008) 0.87
Characterization of cellular senescence mechanisms in human corneal endothelial cells. Aging Cell (2011) 0.86
Curcumin triggers p16-dependent senescence in active breast cancer-associated fibroblasts and suppresses their paracrine procarcinogenic effects. Neoplasia (2013) 0.86
Mre11 modulates the fidelity of fusion between short telomeres in human cells. Nucleic Acids Res (2011) 0.86
Transcriptional down-regulation of the retinoblastoma protein is associated with differentiation and apoptosis in human colorectal epithelial cells. Br J Cancer (2001) 0.85
Small molecule inhibition of p38 MAP kinase extends the replicative life span of human ATR-Seckel syndrome fibroblasts. J Gerontol A Biol Sci Med Sci (2013) 0.84
p16(INK4A) positively regulates p21(WAF1) expression by suppressing AUF1-dependent mRNA decay. PLoS One (2013) 0.84
Nek4 regulates entry into replicative senescence and the response to DNA damage in human fibroblasts. Mol Cell Biol (2012) 0.83
HBP1-mediated transcriptional regulation of DNA methyltransferase 1 and its impact on cell senescence. Mol Cell Biol (2012) 0.81
Activation of p38 MAP kinase and stress signalling in fibroblasts from the progeroid Rothmund-Thomson syndrome. Age (Dordr) (2012) 0.81
Large-scale analysis of protein expression changes in human keratinocytes immortalized by human papilloma virus type 16 E6 and E7 oncogenes. Proteome Sci (2009) 0.78
Senescence evasion in melanoma progression: uncoupling of DNA-damage signaling from p53 activation and p21 expression. Pigment Cell Melanoma Res (2013) 0.77
Chitosan Treatment Delays the Induction of Senescence in Human Foreskin Fibroblast Strains. PLoS One (2015) 0.75
A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci U S A (1995) 32.89
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell (1997) 29.13
THE LIMITED IN VITRO LIFETIME OF HUMAN DIPLOID CELL STRAINS. Exp Cell Res (1965) 21.61
Monoclonal antibodies specific for simian virus 40 tumor antigens. J Virol (1981) 15.59
Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp Cell Res (1994) 6.16
Telomere elongation in immortal human cells without detectable telomerase activity. EMBO J (1995) 6.03
Bypass of senescence after disruption of p21CIP1/WAF1 gene in normal diploid human fibroblasts. Science (1997) 4.97
Isolation of human-p53-specific monoclonal antibodies and their use in the studies of human p53 expression. Eur J Biochem (1986) 4.80
p14ARF links the tumour suppressors RB and p53. Nature (1998) 4.78
Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16. Nature (1995) 4.78
p53-dependent apoptosis produced by Rb-deficiency in the developing mouse lens. Nature (1994) 4.52
Involvement of the cyclin-dependent kinase inhibitor p16 (INK4a) in replicative senescence of normal human fibroblasts. Proc Natl Acad Sci U S A (1996) 4.33
The E7 gene of human papillomavirus type 16 is sufficient for immortalization of human epithelial cells. J Virol (1991) 4.18
Reversible cellular senescence: implications for immortalization of normal human diploid fibroblasts. Mol Cell Biol (1989) 3.89
An immunochemical analysis of the human nuclear phosphoprotein p53. New monoclonal antibodies and epitope mapping using recombinant p53. J Immunol Methods (1992) 3.23
Small peptides activate the latent sequence-specific DNA binding function of p53. Cell (1995) 2.96
The human papillomavirus E7 oncoprotein can uncouple cellular differentiation and proliferation in human keratinocytes by abrogating p21Cip1-mediated inhibition of cdk2. Genes Dev (1997) 2.83
Altered cell cycle regulation in the lens of HPV-16 E6 or E7 transgenic mice: implications for tumor suppressor gene function in development. Genes Dev (1994) 2.72
Inhibition of CDK activity and PCNA-dependent DNA replication by p21 is blocked by interaction with the HPV-16 E7 oncoprotein. Genes Dev (1997) 2.65
Inactivation of p16 in human mammary epithelial cells by CpG island methylation. Mol Cell Biol (1998) 2.64
Inhibitors of cyclin-dependent kinases induce features of replicative senescence in early passage human diploid fibroblasts. Curr Biol (1998) 2.42
Differential disruption of genomic integrity and cell cycle regulation in normal human fibroblasts by the HPV oncoproteins. Genes Dev (1994) 2.32
Transcriptional repression of the D-type cyclin-dependent kinase inhibitor p16 by the retinoblastoma susceptibility gene product pRb. Cancer Res (1994) 2.28
Increased activity of p53 in senescing fibroblasts. Proc Natl Acad Sci U S A (1995) 2.27
E6 of human papillomavirus type 16 can overcome the M1 stage of immortalization in human mammary epithelial cells but not in human fibroblasts. Oncogene (1993) 2.25
Homozygotes for CDKN2 (p16) germline mutation in Dutch familial melanoma kindreds. Nat Genet (1995) 2.11
Alterations in p53 and p16INK4 expression and telomere length during spontaneous immortalization of Li-Fraumeni syndrome fibroblasts. Mol Cell Biol (1995) 1.85
Replicative senescence of human fibroblast-like cells in culture. Physiol Rev (1993) 1.71
Human papillomavirus type 16 E7 alleviates a proliferation block in early passage human mammary epithelial cells. Oncogene (1996) 1.71
SV40-induced immortalization of human cells. Crit Rev Oncog (1994) 1.51
Escape from senescence in human diploid fibroblasts induced directly by mutant p53. Oncogene (1994) 1.48
Differential CDK-inhibitor gene expression in aging human diploid fibroblasts. Exp Gerontol (1996) 1.36
Independent induction of senescence by p16INK4a and p21CIP1 in spontaneously immortalized human fibroblasts. Cell Growth Differ (1998) 1.26
Evidence that transcriptional activation by p53 plays a direct role in the induction of cellular senescence. Oncogene (1996) 1.25
Elevated wild-type p53 protein levels in human epithelial cell lines immortalized by the human papillomavirus type 16 E7 gene. Virology (1994) 1.24
Reinitiation of DNA synthesis and cell division in senescent human fibroblasts by microinjection of anti-p53 antibodies. Mol Cell Biol (1998) 1.19
Perturbation of the p53 response by human papillomavirus type 16 E7. J Virol (1997) 1.06
Mutant p53 rescues human diploid cells from senescence without inhibiting the induction of SDI1/WAF1. Cancer Res (1995) 1.02
Chromosomal instability is correlated with telomere erosion and inactivation of G2 checkpoint function in human fibroblasts expressing human papillomavirus type 16 E6 oncoprotein. Oncogene (1998) 1.01
In vitro reconstruction of tumour initiation in a human epithelium. Oncogene (1994) 0.97
Loss of dependence on IGF-1 for proliferation of human thyroid adenoma cells. Br J Cancer (1988) 0.93
Investigation of the role of G1/S cell cycle mediators in cellular senescence. Exp Cell Res (1993) 0.92
Proliferative lifespan checkpoints: cell-type specificity and influence on tumour biology. Eur J Cancer (1997) 0.89
Expression of p21 is not required for senescence of human fibroblasts. Cancer Res (1996) 0.88
The influence of cell context on the selection pressure for p53 mutation in human cancer. Carcinogenesis (1998) 0.85
Apoptosis in human papillomavirus16 E7-, but not E6-immortalized human uroepithelial cells. Oncogene (1996) 0.84
Spontaneous de-differentiation correlates with extended lifespan in transformed thyroid epithelial cells: an epigenetic mechanism of tumour progression? Int J Cancer (1996) 0.83
Direct growth stimulation of normal human epithelial cells by mutant p53. Mol Carcinog (1993) 0.82
Effect of serum growth factors and phorbol ester on growth and survival of human thyroid epithelial cells expressing mutant ras. Mol Carcinog (1992) 0.79
Metabolic acidosis and fatal myocardial failure after propofol infusion in children: five case reports. BMJ (1992) 7.20
A venue-based method for sampling hard-to-reach populations. Public Health Rep (2001) 6.43
Identification and characterization of the STIM (stromal interaction molecule) gene family: coding for a novel class of transmembrane proteins. Biochem J (2001) 3.77
STIM1: a novel phosphoprotein located at the cell surface. Biochim Biophys Acta (2000) 3.67
Structural details of double-helix observed for DNAs containing alternating purine and pyrimidine sequences. J Mol Biol (1974) 3.33
Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms' tumour. Nature (1993) 3.24
Cellular senescence in naevi and immortalisation in melanoma: a role for p16? Br J Cancer (2006) 3.23
P53 in tumour pathology: can we trust immunocytochemistry? J Pathol (1992) 3.00
A new and simple questionnaire to identify people at increased risk for undiagnosed diabetes. Diabetes Care (1995) 2.99
Telomerase prevents the accelerated cell ageing of Werner syndrome fibroblasts. Nat Genet (2000) 2.26
Plasma membrane Ca2+-ATPase extrudes Ca2+ from hair cell stereocilia. J Neurosci (1998) 2.14
Models of triple-stranded polynucleotides with optimised stereochemistry. Nucleic Acids Res (1976) 2.06
High frequency of ras oncogene activation in all stages of human thyroid tumorigenesis. Oncogene (1989) 1.98
Early bactericidal activity of high-dose rifampin in patients with pulmonary tuberculosis evidenced by positive sputum smears. Antimicrob Agents Chemother (2007) 1.93
A prospective comparative study of the AMO ARRAY zonal-progressive multifocal silicone intraocular lens and a monofocal intraocular lens. Ophthalmology (1999) 1.84
Molecular cloning of a novel human gene (D11S4896E) at chromosomal region 11p15.5. Genomics (1996) 1.80
A pragmatic approach to the analysis of DNA histograms with a definable G1 peak. Cytometry (1987) 1.79
Does AIDS impair the absorption of antituberculosis agents? Int J Tuberc Lung Dis (1998) 1.77
Characterisation of human thyroid epithelial cells immortalised in vitro by simian virus 40 DNA transfection. Br J Cancer (1989) 1.68
Role for the plasmodium falciparum digestive vacuole in chloroquine resistance. Biochem Pharmacol (1998) 1.65
Otitis media-related antibiotic prescribing patterns, outcomes, and expenditures in a pediatric medicaid population. Pediatrics (1997) 1.63
Silicone arthroplasty for trapeziometacarpal arthritis. J Hand Surg Br (2002) 1.63
The relationship between height velocity and growth hormone secretion in short prepubertal children. Clin Endocrinol (Oxf) (1987) 1.61
Diabetes mellitus in Egypt: glycaemic control and microvascular and neuropathic complications. Diabet Med (1998) 1.61
Birefringence imaging directly reveals architectural dynamics of filamentous actin in living growth cones. Mol Biol Cell (1999) 1.61
Continuous intercostal nerve block for pain relief after thoracotomy. Ann Thorac Surg (1988) 1.58
Acidification of the male reproductive tract by a proton pumping (H+)-ATPase. Nat Med (1996) 1.55
The effects of steel and titanium mandibular reconstruction plates on photon and electron beams. Br J Radiol (1990) 1.53
Lichen sclerosus et atrophicus. A common and distinctive cause of phimosis in boys. Arch Dermatol (1984) 1.50
Equivalent expression of paternally and maternally inherited WT1 alleles in normal fetal tissue and Wilms' tumours. Oncogene (1992) 1.50
Value of factor VIII related antigen as a means of demonstrating extramedullary megakaryopoiesis. J Clin Pathol (1984) 1.49
Correlation between DNA flow cytometric and nucleolar organizer region data in non-Hodgkin's lymphomas. J Pathol (1988) 1.49
Escape from senescence in human diploid fibroblasts induced directly by mutant p53. Oncogene (1994) 1.48
Survey of physician practice behaviors related to diabetes mellitus in the U.S. Physician adherence to consensus recommendations. Diabetes Care (1993) 1.47
A community-level HIV prevention intervention for inner-city women: results of the women and infants demonstration projects. Am J Public Health (2000) 1.46
Posttranslational modifications of p53 in replicative senescence overlapping but distinct from those induced by DNA damage. Mol Cell Biol (2000) 1.46
Prostatectomy in the over 80-year-old. Br J Urol (1989) 1.46
Activated ras oncogenes in human thyroid cancers. Cancer Res (1988) 1.45
Cytostatic therapy for AA amyloidosis complicating psoriatic spondyloarthropathy. Rheumatology (Oxford) (2003) 1.43
"Should we treat leuchaemia in children?". Med J Aust (2001) 1.40
Splicing of exon 5 in the WT1 gene is disrupted in Wilms' tumour. Eur J Cancer (1995) 1.39
Hyaluronic acid: structure of a fully extended 3-fold helical sodium salt and comparison with the less extended 4-fold helical forms. J Mol Biol (1975) 1.39
Bladder irrigation with chlorhexidine for the prevention of urinary infection after transurethral operations: a prospective controlled study. J Urol (1987) 1.39
Anomalous extensor muscles of the hand: a review. J Hand Surg Am (1999) 1.38
Care of the acutely injured hand. Br Med J (Clin Res Ed) (1985) 1.37
The role of NAD(P)H: quinone reductase (EC 1.6.99.2, DT-diaphorase) in the reductive bioactivation of the novel indoloquinone antitumor agent EO9. Cancer Commun (1991) 1.32
Hyaluronic acid: molecular conformations and interactions in two sodium salts. J Mol Biol (1975) 1.29
The polymerase chain reaction: miracle or mirage? A critical review of its uses and limitations in diagnosis and research. J Pathol (1990) 1.29
The epidemiology of diabetes and pregnancy in the U.S., 1988. Diabetes Care (1995) 1.28
The use of Sternberg's memory-scanning paradigm in assessing effects of chemical exposure. Hum Factors (1981) 1.28
Comparison between a physiological and a pharmacological stimulus of growth hormone secretion: response to stage IV sleep and insulin-induced hypoglycaemia. Lancet (1985) 1.27
Zinc finger point mutations within the WT1 gene in Wilms tumor patients. Proc Natl Acad Sci U S A (1992) 1.26
Effects of levodopa on laryngeal muscle activity for voice onset and offset in Parkinson disease. J Speech Lang Hear Res (2001) 1.26
Immunohistochemical localisation of factor VIII-related antigen in Hodgkin's disease. J Clin Pathol (1984) 1.25
Evidence that transcriptional activation by p53 plays a direct role in the induction of cellular senescence. Oncogene (1996) 1.25
Ataxia telangiectasia: an inherited human disorder involving hypersensitivity to ionizing radiation and related DNA-damaging chemicals. Annu Rev Genet (1979) 1.25
Oxygen-depleted zones inside reproductive structures of Brassicaceae: implications for oxygen control of seed development. Can J Bot (1999) 1.24
Overexpression of the c-erbB-2 oncoprotein: why does this occur more frequently in ductal carcinoma in situ than in invasive mammary carcinoma and is this of prognostic significance? Eur J Cancer (1992) 1.24
Liver disease in patients with joint symptoms. Ann Rheum Dis (1974) 1.23
A quantitative study of mast cells in Hodgkin's disease. J Clin Pathol (1984) 1.23
The anatomical basis of the groin flap. Plast Reconstr Surg (1972) 1.22
Simian virus 40 large T antigen (SV40LTAg) primer specific DNA amplification in human pleural mesothelioma tissue. Thorax (1996) 1.22
Microsatellite instability and other molecular abnormalities in non-small cell lung cancer. Cancer Res (1995) 1.22
Flow cytometric fluorescence emission spectrum analysis of Hoechst-33342-stained DNA in chicken thymocytes. Cytometry (1985) 1.21
Mutation of the p53 gene in a differentiated human thyroid carcinoma cell line, but not in primary thyroid tumours. Oncogene (1991) 1.20
A third Wilms' tumor locus on chromosome 16q. Cancer Res (1992) 1.20
Transient ectopic expression of PTEN in thyroid cancer cell lines induces cell cycle arrest and cell type-dependent cell death. Hum Mol Genet (2001) 1.20
Reinitiation of DNA synthesis and cell division in senescent human fibroblasts by microinjection of anti-p53 antibodies. Mol Cell Biol (1998) 1.19
Use of bromodeoxyuridine for cell kinetic studies in intact animals. Cell Tissue Kinet (1986) 1.17
Physical randomization of tissue architecture: an alternative to systemic sampling. J Microsc (1982) 1.17
TIMP1 and adverse prognosis in non-small cell lung cancer. Clin Cancer Res (1996) 1.17
Screening for diabetes mellitus in adults. The utility of random capillary blood glucose measurements. Diabetes Care (1995) 1.16
Functional myocardial impairment in children treated with anthracyclines for cancer. Lancet (1991) 1.16
Herd fertility and Corynebacterium haemolyticum in bovine semen. Vet Rec (1968) 1.16
The self-referencing oxygen-selective microelectrode: detection of transmembrane oxygen flux from single cells. J Exp Biol (1999) 1.15
Vaccination status of children in the Women, Infants, and Children (WIC) Program: are we doing enough to improve coverage? Am J Prev Med (2001) 1.15
The effect of artesunate combined with standard antimalarials against chloroquine-sensitive and chloroquine-resistant strains of Plasmodium falciparum in vitro. Trans R Soc Trop Med Hyg (2000) 1.14
Microbiology of the urethral (frequency and dysuria) syndrome. A controlled study with 5-year review. Br J Urol (1989) 1.13
Effect of occupational exposure to elemental mercury on short term memory. Br J Ind Med (1983) 1.13
In situ analysis of pH gradients in mosquito larvae using non-invasive, self-referencing, pH-sensitive microelectrodes. J Exp Biol (2001) 1.13
The active site regions of lacZ and ebg beta-galactosidases are homologous. J Biol Chem (1983) 1.13
Double J stents. A review of 100 patients. Br J Urol (1986) 1.13
Gas treatment in trickle-bed biofilters: biomass, how much is enough? Biotechnol Bioeng (1997) 1.12
Activated ras and ret oncogenes induce over-expression of c-met (hepatocyte growth factor receptor) in human thyroid epithelial cells. Oncogene (1997) 1.12
c-Ha-ras-1 alleles in bladder cancer, Wilms' tumour and malignant melanoma. Hum Genet (1988) 1.12
Vaccination status of children living in rural areas in the United States: are they protected? Am J Prev Med (2001) 1.11
Consecutive-dose pharmacokinetics of rifapentine in patients diagnosed with pulmonary tuberculosis. Int J Tuberc Lung Dis (2004) 1.11
An outbreak of Serratia marcescens infections in a neonatal unit. Lancet (1984) 1.11
Control of human thyroid follicular cell proliferation in suspension and monolayer culture. Mol Cell Endocrinol (1987) 1.11
The "seagull" flap for syndactyly. Br J Plast Surg (1982) 1.09
Adipose tissue stearoyl-CoA desaturase mRNA is increased by obesity and decreased by polyunsaturated fatty acids. Am J Physiol (1996) 1.09
Ha-ras restriction fragment length polymorphisms in colorectal cancer. Br J Cancer (1988) 1.09
Enhanced radiosensitivity of cultured fibroblasts from ataxia telangiectasia heterozygotes manifested by defective colony-forming ability and reduced DNA repair replication after hypoxic gamma-irradiation. Cancer Res (1979) 1.07